Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Radiotherapy for metastatic prostate cancer.

Aparicio A, Thall P, Logothetis C.

Lancet. 2019 Sep 7;394(10201):829-830. doi: 10.1016/S0140-6736(19)31783-0. No abstract available.

PMID:
31498098
2.

Radiotherapy for metastatic prostate cancer.

Gouda MA.

Lancet. 2019 Sep 7;394(10201):829. doi: 10.1016/S0140-6736(19)31782-9. No abstract available.

PMID:
31498097
3.

Radiotherapy for metastatic prostate cancer-Authors' reply.

Parker CC, James ND, Brawley CD, Clarke NW, Parmar MKB.

Lancet. 2019 Sep 7;394(10201):830. doi: 10.1016/S0140-6736(19)31829-X. No abstract available.

PMID:
31498099
4.

[Local radiotherapy for patients with newly diagnosed, metastatic prostate cancer].

Guckenberger M.

Strahlenther Onkol. 2019 Apr;195(4):362-364. doi: 10.1007/s00066-019-01435-8. German. No abstract available.

PMID:
30767033
5.

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED.

JAMA. 2006 Nov 15;296(19):2329-35.

PMID:
17105795
6.

Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging.

Nehra A, Parker WP, Haloi R, Park SS, Mynderse LA, Lowe VJ, Davis BJ, Quevedo JF, Johnson GB, Kwon ED, Karnes RJ.

J Urol. 2018 Mar;199(3):726-733. doi: 10.1016/j.juro.2017.09.033. Epub 2017 Sep 12.

PMID:
28916273
7.

Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review.

Becker JA, Berg KD, Røder MA, Brasso K, Iversen P.

Scand J Urol. 2018 Feb;52(1):1-7. doi: 10.1080/21681805.2017.1363816. Epub 2017 Aug 18. Review.

PMID:
28818014
8.

Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.

Sooriakumaran P, Nyberg T, Akre O, Haendler L, Heus I, Olsson M, Carlsson S, Roobol MJ, Steineck G, Wiklund P.

BMJ. 2014 Feb 26;348:g1502. doi: 10.1136/bmj.g1502.

9.

Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer.

Huang J, Kestin LL, Ye H, Wallace M, Martinez AA, Vicini FA.

Radiother Oncol. 2011 Jan;98(1):81-6. doi: 10.1016/j.radonc.2010.09.012. Epub 2010 Oct 14.

PMID:
20951450
10.

Editorial comment on: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Yossepowitch O.

Eur Urol. 2009 Oct;56(4):676-7. doi: 10.1016/j.eururo.2009.05.043. Epub 2009 May 29. No abstract available.

PMID:
19501457
11.

Editorial comment on: Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Da Pozzo LF.

Eur Urol. 2009 Oct;56(4):675-6. doi: 10.1016/j.eururo.2009.05.042. Epub 2009 May 29. No abstract available.

PMID:
19501455
12.

Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.

Servoll E, Sæter T, Vlatkovic L, Nesland JM, Waaler G, Axcrona K.

Scand J Urol. 2015 Jun;49(3):218-23. doi: 10.3109/21681805.2014.982168. Epub 2014 Nov 27.

PMID:
25428750
13.

Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No.

Ristau BT, Smaldone MC.

Int Braz J Urol. 2016 Sep-Oct;42(5):880-882. doi: 10.1590/S1677-5538.IBJU.2016.05.05. No abstract available.

14.

Prostate cancer: non-metastatic.

Wilt T.

Clin Evid. 2002 Jun;(7):812-23. Review. No abstract available. Update in: Clin Evid. 2003 Jun;(9):973-85.

PMID:
12230707
15.
16.

Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes.

Costa WH, Guimarães GC.

Int Braz J Urol. 2016 Sep-Oct;42(5):876-879. doi: 10.1590/S1677-5538.IBJU.2016.05.04. No abstract available.

17.

Local Treatment of the Prostate in Metastatic Prostate Cancer: Need to Change the Concept?

Saito K.

Eur Urol. 2017 Jul;72(1):20-21. doi: 10.1016/j.eururo.2016.06.008. Epub 2016 Jun 20. No abstract available.

PMID:
27339835
18.

[The treatment of locally advanced (T3) prostatic carcinoma using radical prostatectomy or radiotherapy. A review].

van den Ouden D, Schröder FH.

Tijdschr Gerontol Geriatr. 1998 Apr;29(2):74-9. Review. Dutch.

PMID:
9615377
20.

Supplemental Content

Support Center